Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial

BACKGROUND: There are no effective therapies for patients with coronavirus disease-2019 (COVID-19). METHODS: Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) (n = 23) and control (n = 18). The primary outcome were the tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guoming, Yuan, Mei, Li, Haihong, Deng, Changsheng, Wang, Qi, Tang, Yexiao, Zhang, Hongying, Yu, Weisheng, Xu, Qin, Zou, Yuanyuan, Yuan, Yueming, Guo, Jiawen, Jin, Chunming, Guan, Xiangdong, Xie, Fengjie, Song, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605811/
https://www.ncbi.nlm.nih.gov/pubmed/33152450
http://dx.doi.org/10.1016/j.ijantimicag.2020.106216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605811/
https://www.ncbi.nlm.nih.gov/pubmed/33152450
http://dx.doi.org/10.1016/j.ijantimicag.2020.106216

Ejemplares similares